Amedeo Smart

Free Medical Literature Service



Ovarian Neoplasms

  Free Subscription

Articles published in
Curr Opin Obstet Gynecol
    February 2024
  1. ALI M, Tewari KS
    A review of racial disparities in ovarian cancer and clinical trials.
    Curr Opin Obstet Gynecol. 2024;36:23-27.
    >> Share

  2. SALUTARI V, Giudice E, Lorusso D
    Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives.
    Curr Opin Obstet Gynecol. 2024;36:9-17.
    >> Share

    January 2024
  3. GARCIA-ILLESCAS D, Mazzeo R, Garcia-Duran C, Oaknin A, et al
    The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era.
    Curr Opin Obstet Gynecol. 2024 Jan 3. doi: 10.1097/GCO.0000000000000934.
    >> Share

    August 2023
  4. HABER HR, French HM, Movilla PR, Isaacson KB, et al
    Take it or leave it: oophorectomy at the time of benign hysterectomy.
    Curr Opin Obstet Gynecol. 2023;35:344-351.
    >> Share

    February 2023
  5. PRAISS AM, Moukarzel LA, Zivanovic O
    Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer?
    Curr Opin Obstet Gynecol. 2023;35:21-26.
    >> Share

  6. TYMON-ROSARIO J, Gorman M, Richardson DL, Washington C, et al
    Advances in antibody-drug conjugates for gynecologic malignancies.
    Curr Opin Obstet Gynecol. 2023;35:6-14.
    >> Share

  7. QUESADA S, Bini M, Lebreton C, Ray-Coquard I, et al
    Update on new treatments for rare ovarian tumours.
    Curr Opin Obstet Gynecol. 2023;35:27-33.
    >> Share

    October 2022
  8. KRAUSE D, Richardson DL
    Is there a role for secondary debulking in ovarian cancer? A review of the current literature.
    Curr Opin Obstet Gynecol. 2022 Oct 14. pii: 00001703-990000000-00030.
    >> Share

    February 2021
    PARP inhibitors in the treatment of ovarian cancer: a review.
    Curr Opin Obstet Gynecol. 2021;33:1-6.
    >> Share

  10. HINCHCLIFF E, Chelariu-Raicu A, Westin SN
    Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance.
    Curr Opin Obstet Gynecol. 2021;33:19-25.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016